Bracket Changes Hands Again

It may not be news to digital health sector watchers that Bracket, a privately held clinical trial technology provider, was sold again. On March 28, 2017, San Francisco private equity firm Genstar Capital purchased the company for an undisclosed price. Bracket, a Pennsylvania-based clinical trial technology, has changed hands several times over the years. Bracket serves biotechnology and pharmaceutical companies, as well as clinial research organizations. It leverages Bracket eCOA™, a platform for electronic clinical outcomes assessments that collects information from patients (ePRO), clinicians (eClinRO) and other observers (eObsRO). The company started off as a division of United... Read More »